Monitoring the effect of first line treatment in RAS/RAF mutated metastatic colorectal cancer by serial analysis of tumor specific DNA in plasma

por Thomsen, C. B., Hansen, T. F., Andersen, R. F., Lindebjerg, J., Jensen, L. H., Jakobsen, A.
Publicado 2018

Redefining high-risk patients with stage II colon cancer by risk index and microRNA-21: results from a population-based cohort

por Hansen, T F, Kjær-Frifeldt, S, Christensen, R D, Morgenthaler, S, Blondal, T, Lindebjerg, J, Sørensen, F B, Jakobsen, A
Publicado 2014

The prognostic importance of miR-21 in stage II colon cancer: a population-based study

por Kjaer-Frifeldt, S, Hansen, T F, Nielsen, B S, Joergensen, S, Lindebjerg, J, Soerensen, F B, dePont Christensen, R, Jakobsen, A
Publicado 2012